$SG

Sweetgreen (SG) Q2 2026 Earnings Call Transcript

Sweetgreen (SG) reported Q2 2026 revenue of $192.7M, up 4% YoY, driven by 36 net new restaurant openings. Same-store sales fell 6.2%. Restaurant-level margin was 13.1% and adjusted EBITDA was a $0.2M loss. FY2026 guidance was revised for cyclospora impacts, with comparable sales expected to decline 7% to 8% and restaurant margin 10.5% to 11.0%.

Original reporting
Published Aug 14, 2026, 12:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sweetgreen (SG) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SGBearishHigh
01

Why it matters

The cyclospora outbreak and related consumer concern are quantified as a direct headwind to FY2026 comparable sales (200 to 300 bps) and EBITDA ($7M to $10M), prompting guidance revisions across sales, margins, and profitability.

02

Market read

Traders can reprice Sweetgreen’s forward demand and margin trajectory based on the explicit FY2026 guidance cuts and the quantified outbreak/recall risks.

03

What to watch

The company cites potential 150 bps cost savings from waste reduction and reports throughput improvements, which could partially offset the margin hit if execution holds.

Relevance 9/10Novelty 9/10Timing: post-call, pre-positioning for FY2026 guidance and cyclospora headline risk

Background

Sweetgreen is in a transformation plan emphasizing Infinite Kitchen automation, menu mix shifts toward wraps, and throughput/accountability improvements.

Company-level read

Ticker impact

$SGBearishHigh confidence
Context

Sweetgreen reported Q2 revenue of $192.7M, same-store sales down 6.2%, and revised FY2026 guidance due to the cyclospora outbreak.

Expected impact

Bias toward downside or elevated volatility until investors underwrite the cyclospora duration and margin recovery path.

Evidence & confidence

The article discloses multiple forward-looking revisions: FY comparable sales expected to decline 7% to 8% (cyclospora impact), restaurant-level margin guidance cut to 10.5% to 11.0%, and FY adjusted EBITDA revised to a loss of $27M to $23M.

Market effects

Fresh-casual and quick-service peers may face read-across risk if cyclospora headlines continue to suppress produce-driven demand.

No specific regional macro impact beyond New York and Seattle transaction comps returning positive in Q2.

Limited, as the driver is a US-linked public health headline and company-specific recall.

Counterpoint

Digital revenue mix (66.3% total, owned 38.8%) and wrap-driven frequency gains could cushion unit economics if the outbreak fades faster than feared.

Key entities

  • Sweetgreen, Inc.

    Reported Q2 2026 results and revised FY2026 guidance due to cyclospora-related demand disruption and a jalapeño recall.

  • Jonathan Neman

    CEO attributed sales and transaction trends to wraps value positioning and throughput process changes.

  • Jamie McConnell

    CFO quantified cost structure pressures and the cyclospora outbreak impact on guidance.

Related articles

$SGHighAI 8/10

Sweetgreen Says Wraps Are a Hit With Diners, But Cyclospora Scare Clouds Outlook — BigGo Finance

Sweetgreen Inc. (NYSE:SG) said its lower-priced wraps are driving loyalty and transactions, with CEO Jonathan Neman citing about a 20% incidence rate since the national launch and a 30-day return rate above the Harvest Bowl. Cyclospora-related negative headlines in mid-July led the company to cut full-year 2026 guidance. Q2 revenue was $192.7M (+4% YoY), but comparable sales fell 6.2% and restaurant margin dropped to 13.1%.

$SGHighAI 8/10

After a Wraps Win, Sweetgreen Faces a Fresh Setback

Sweetgreen introduced lower-priced wraps after a weak Q1 to improve value perception and drive repeat visits. Wraps reached about a 20% incidence rate and improved retention, but same-store sales fell 6.2% in Q2. Revenue rose ~4% to $192.7M. A cyclospora-related demand hit led to a lowered full-year outlook and guidance.

$SGMed

Parasite Outbreak Fears Crush Restaurant Sales Weeks After RFK Jr. Said It Was “Under Control”

On July 21, HHS Secretary Robert F. Kennedy Jr. said the multistate cyclosporiasis outbreak tied to iceberg lettuce was “under control.” By Aug. 5, the CDC reported 6,358 illnesses in 15 states, 278+ hospitalizations, and two deaths. The FDA linked the recall to Taylor Farms, and restaurant chains including Sweetgreen (SG) and Salad and Go filed for Chapter 11, citing outbreak-related demand impacts.

$SGHighAI 9/10

Sweetgreen Q2 Earnings Call Highlights

Sweetgreen (NYSE:SG) reported Q2 comparable transaction declines narrowing from -11.2% in Q1 to about -3% in April-May and near flat in June. Restaurant-level profit was $25.2M (13.1% margin) and adjusted EBITDA was a $0.2M loss. Wraps drove frequency but lower check weighed mix. Sweetgreen cut 2026 outlook for disruption, expecting comps -8% to -7% and adjusted EBITDA loss of $27M to $23M.

$SGHighAI 9/10

Sweetgreen Shares Slide After Weak Second-Quarter Results and Lower Outlook

Sweetgreen (NYSE:SG) shares fell about 15% premarket after it reported Q2 2026 results that missed expectations. Revenue rose 3.8% to $192.7M, but GAAP loss widened to $0.22 per share. Comparable sales fell 6.2% and restaurant margin dropped to 13.1% from 18.9%. Sweetgreen cut full-year EBITDA guidance to about -$25M at midpoint, citing a cyclospora outbreak.

$SGMedAI 8/10

Sweetgreen Stumbles Again. Are the Turnaround Chances Gone?

Sweetgreen (NYSE: SG) reported another weak quarter after hours, with shares down double digits before partially recovering. Same-store sales decline narrowed to 6.2% in Q2 from 12.8% in Q1, but a cyclospora outbreak hurt July comps, cutting full-year guidance to same-store sales down 7%-8% and adjusted EBITDA loss of $23M-$27M. Management cited improving throughput and wrap adoption.